quinoxalines has been researched along with caroverine in 38 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (15.79) | 18.7374 |
1990's | 9 (23.68) | 18.2507 |
2000's | 19 (50.00) | 29.6817 |
2010's | 3 (7.89) | 24.3611 |
2020's | 1 (2.63) | 2.80 |
Authors | Studies |
---|---|
Ehrenberger, K; Felix, D | 2 |
Eberhardt, G; Haller, R; König, P; Koppi, S | 1 |
Ishida, M; Shinozaki, H | 1 |
Kudo, Y; Shibata, S | 1 |
Iida, H; Sakurai, Y; Tsukagoshi, S; Tsuruo, T | 1 |
Ishida, Y; Ozaki, H; Shibata, S | 1 |
Anderer, P; Grünberger, J; König, P; Linzmayer, L; Saletu, B | 2 |
Denk, DM; Ehrenberger, K; Franz, P; Heinzl, H | 1 |
Fartacek, R; Geretsegger, C | 1 |
Domeisen, H; Häusler, R; Hotz, MA | 1 |
Arnold, W; Ehrenberger, K; Felix, D; Oestreicher, E | 1 |
Conca, A; König, P; Lugmayer, B | 1 |
Ehrenberger, K | 2 |
Ehrenberger, K; Felix, D; Oestreicher, E | 1 |
Bieberschulte, W; Ehrenberger, K; Frei, K; Kozlov, AV; Nohl, H; Udilova, N | 1 |
Ehrenberger, K; Hummel, T; Quint, C; Temmel, AF | 1 |
Hummel, T | 1 |
Kratzer, U; Schmidt, WJ | 1 |
HITZENBERGER, G; HORNYKIEWICZ, O; ZELLNER, H | 1 |
Chen, Z; Duan, M; Ruan, R; Tan, L; Ulfendahl, M | 2 |
Bieberschulte, W; Dietrich, B; Kozlov, AV; Nohl, H; Udilova, N | 1 |
Temmel, AF; Toth, J | 1 |
Heermann, R; Lenarz, T; Schwab, B | 1 |
Alpini, D; Capobianco, S; Cesarani, A; Giuliano, DA | 1 |
Bieberschulte, W; Gille, L; Jurek, D; Marian, B; Nohl, H; Rohr-Udilova, N; Schulte-Hermann, R | 1 |
Borg, E; Chen, Z; Duan, M; Laurell, G; Qiu, J; Ruan, R; Ulfendahl, M | 1 |
Born, J; Gais, S; Rasch, B; Wagner, U | 1 |
Logvinov, SV; Plotnikov, MB; Potapov, AV; Varakuta, EIu; Zhdankina, AA | 1 |
Logvinov, SV; Plotnikov, MB; Potapov, AV; Varakuta, EY; Zhdankina, AA | 1 |
Born, J; Hallschmid, M; Hubold, C; Klement, J; Knispel, A; Oltmanns, KM; Pais, I; Peters, A; Schultes, B | 1 |
Brunner, M; Enzenhofer, E; Haymerle, G; Heiduschka, G; Kadletz, L; Kotowski, U; Stanisz, I; Thurnher, D | 1 |
Harless, L; Liang, J | 1 |
Ansari, TM; Raza, A | 1 |
Aeumjaturapat, S; Chusakul, S; Kanjanaumporn, J; Seresirikachorn, K; Snidvongs, K | 1 |
3 review(s) available for quinoxalines and caroverine
Article | Year |
---|---|
[Drug therapy for disturbances of smelling].
Topics: Adrenal Cortex Hormones; Controlled Clinical Trials as Topic; Dopamine; Humans; Olfaction Disorders; Quinoxalines; Smell; Theophylline; Vasodilator Agents; Vitamin A; Vitamin B Complex; Zinc | 2004 |
Pharmacologic treatment for postviral olfactory dysfunction: a systematic review.
Topics: Adrenal Cortex Hormones; Ginkgo biloba; Humans; Minocycline; Olfaction Disorders; Quinoxalines; Thioctic Acid; Vitamin A; Zinc Sulfate | 2016 |
Smell and taste dysfunction in patients with SARS-CoV-2 infection: A review of epidemiology, pathogenesis, prognosis, and treatment options.
Topics: Adrenal Cortex Hormones; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Incidence; Olfaction Disorders; Olfactory Mucosa; Olfactory Perception; Pandemics; Pneumonia, Viral; Practice Guidelines as Topic; Prognosis; Quinoxalines; Remission, Spontaneous; SARS-CoV-2; Taste Perception; Vitamin A | 2020 |
9 trial(s) available for quinoxalines and caroverine
Article | Year |
---|---|
Calcium-channel-blocking agent in the treatment of acute alcohol withdrawal--caroverine versus meprobamate in a randomized double-blind study.
Topics: Adult; Aged; Alcohol Withdrawal Delirium; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Meprobamate; Middle Aged; Psychoses, Alcoholic; Quinoxalines | 1987 |
Acute central effects of the calcium channel blocker and antiglutamatergic drug caroverine. Double-blind, placebo-controlled, EEG mapping and psychometric studies after intravenous and oral administration.
Topics: Administration, Oral; Adult; Analysis of Variance; Arousal; Brain Mapping; Calcium Channel Blockers; Central Nervous System Agents; Double-Blind Method; Electroencephalography; Excitatory Amino Acid Antagonists; Female; Humans; Injections, Intravenous; Male; Psychometrics; Quinoxalines | 1995 |
On the cerebro-protective effects of caroverine, a calcium-channel blocker and antiglutamatergic drug: double-blind, placebo-controlled, EEG mapping and psychometric studies under hypoxia.
Topics: Adult; Brain; Calcium Channel Blockers; Double-Blind Method; Electroencephalography; Excitatory Amino Acid Antagonists; Female; Humans; Hypoxia; Male; Placebos; Psychometrics; Quinoxalines; Reference Values | 1996 |
Caroverine in tinnitus treatment. A placebo-controlled blind study.
Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Psychoacoustics; Quinoxalines; Single-Blind Method; Time Factors; Tinnitus | 1997 |
Does a glutamate receptor blocker (Caroverine) enhance haloperidol in the treatment of schizophrenia?
Topics: Adult; Antipsychotic Agents; Drug Synergism; Excitatory Amino Acid Antagonists; Female; Haloperidol; Humans; Male; Middle Aged; Pilot Projects; Psychiatric Status Rating Scales; Quinoxalines; Retrospective Studies; Schizophrenia; Schizophrenic Psychology | 1999 |
The quinoxaline derivative caroverine in the treatment of sensorineural smell disorders: a proof-of-concept study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Humans; Male; Middle Aged; N-Methylaspartate; Olfaction Disorders; Quinoxalines; Sensory Thresholds; Smell; Zinc Sulfate | 2002 |
[Use of the round window micro cath for inner ear therapy - results of a placebo-controlled, prospective study on chronic tinnitus].
Topics: Administration, Topical; Adult; Aged; Auditory Threshold; Catheters, Indwelling; Chronic Disease; Ear, Inner; Endoscopy; Female; Glutamic Acid; Humans; Infusion Pumps; Lidocaine; Loudness Perception; Male; Middle Aged; Pain Measurement; Patient Satisfaction; Quinoxalines; Round Window, Ear; Tinnitus; Treatment Outcome | 2004 |
Visual-procedural memory consolidation during sleep blocked by glutamatergic receptor antagonists.
Topics: Adult; Cross-Over Studies; Discrimination Learning; Double-Blind Method; Excitatory Amino Acid Antagonists; Humans; Ketamine; Male; Memory; Photic Stimulation; Quinoxalines; Sleep | 2008 |
Blocking AMPA receptor signalling by caroverine infusion does not affect counter-regulation of hypoglycaemia in healthy men.
Topics: Adrenocorticotropic Hormone; Adult; Analysis of Variance; Blood Glucose; Double-Blind Method; Epinephrine; Glucagon; Humans; Hydrocortisone; Hypoglycemia; Infusions, Intravenous; Male; Norepinephrine; Quinoxalines; Receptors, AMPA; Signal Transduction; Young Adult | 2009 |
26 other study(ies) available for quinoxalines and caroverine
Article | Year |
---|---|
Caroverine depresses the activity of cochlear glutamate receptors in guinea pigs: in vivo model for drug-induced neuroprotection?
Topics: Animals; Cochlea; Excitatory Amino Acid Antagonists; Female; Glutamic Acid; Guinea Pigs; Male; Quinoxalines; Receptors, Glutamate | 1992 |
Reduction of glutamate responses by caroverine at the crayfish neuromuscular junction.
Topics: Animals; Astacoidea; Evoked Potentials; Glutamates; Glutamic Acid; Neuromuscular Junction; Quinoxalines | 1983 |
Effects of caroverine and diltiazem on synaptic responses, L-glutamate-induced depolarization and potassium efflux in the frog spinal cord.
Topics: Animals; Benzazepines; Diltiazem; Evoked Potentials; Glutamates; Glutamic Acid; In Vitro Techniques; Microelectrodes; Motor Neurons; Neuromuscular Depolarizing Agents; Potassium; Quinoxalines; Rana catesbeiana; Spinal Nerve Roots; Synapses; Tetrodotoxin; Vasodilator Agents | 1984 |
Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors.
Topics: Animals; Calcium Channel Blockers; Calcium-Binding Proteins; Calmodulin; Clomipramine; Doxorubicin; Drug Resistance; Kinetics; Leukemia P388; Leukemia, Experimental; Mice; Prenylamine; Quinoxalines; Trifluoperazine; Verapamil; Vincristine | 1982 |
Vasorelaxant action of caroverine fumarate (a quinoxaline derivative), a calcium-blocking agent.
Topics: Animals; Aorta, Thoracic; Calcium; Hindlimb; In Vitro Techniques; Potassium; Quinoxalines; Rats; Regional Blood Flow; Vasodilator Agents; Verapamil | 1980 |
Receptor pharmacological models for inner ear therapies with emphasis on glutamate receptors: a survey.
Topics: Animals; Cochlea; Ear Diseases; Ear, Inner; gamma-Aminobutyric Acid; Guinea Pigs; Hair Cells, Auditory; Humans; Magnesium; N-Methylaspartate; Neurons, Afferent; Quinoxalines; Receptors, AMPA; Receptors, Metabotropic Glutamate | 1995 |
Infusional high-dose application of the calcium-channel-blocking and antiglutamatergic agent caroverine in the treatment of alcohol withdrawal (DSM-III-R 291.80).
Topics: Adult; Alcohols; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Calcium Channel Blockers; Excitatory Amino Acid Antagonists; Female; Humans; Infusion Pumps; Infusions, Intravenous; Male; Middle Aged; N-Methylaspartate; Pilot Projects; Quinoxalines; Substance Withdrawal Syndrome | 1998 |
Caroverine in tinnitus treatment.
Topics: Female; Humans; Male; Middle Aged; Pilot Projects; Quinoxalines; Research Design; Single-Blind Method; Tinnitus | 1998 |
New approaches for inner ear therapy with glutamate antagonists.
Topics: Animals; Cochlear Diseases; Excitatory Amino Acid Antagonists; Guinea Pigs; Hair Cells, Auditory, Inner; Infusion Pumps, Implantable; Iontophoresis; Memantine; Neurons, Afferent; Quinoxalines | 1999 |
Clinical experience with caroverine in inner ear diseases.
Topics: Cochlea; Free Radicals; Hair Cells, Auditory, Inner; Humans; Mitochondria; Neurons, Afferent; Presbycusis; Quinoxalines; Receptors, Glutamate; Synapses; Tinnitus | 2002 |
Different action of memantine and caroverine on glutamatergic transmission in the mammalian cochlea.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Cochlea; Dopamine Agents; Female; Glutamic Acid; Guinea Pigs; Hair Cells, Auditory, Inner; Memantine; N-Methylaspartate; Neurons, Afferent; Quinoxalines | 2002 |
The antioxidant activity of caroverine.
Topics: Analysis of Variance; Antioxidants; Calcium Channel Blockers; Excitatory Amino Acid Antagonists; Hydroxyl Radical; Lipid Peroxidation; Quinoxalines; Superoxides; Vitamin E | 2003 |
[Therapy of olfactory loss].
Topics: Antioxidants; Humans; Nerve Growth Factors; Olfaction Disorders; Olfactory Nerve; Quinoxalines; Receptors, N-Methyl-D-Aspartate; Thioctic Acid; Treatment Outcome; Zinc | 2003 |
Caroverine inhibits the conditioned place aversion induced by naloxone-precipitated morphine withdrawal in rats.
Topics: Analgesics, Opioid; Animals; Avoidance Learning; Conditioning, Classical; Male; Morphine; Naloxone; Narcotic Antagonists; Quinoxalines; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 2003 |
[Experimental-pharmacological and clinical studies on a new spasmolytic "Spadon" (test name P 201-1)].
Topics: Analgesics; Analgesics, Non-Narcotic; Antipyretics; Biomedical Research; Cardiovascular Agents; Muscle Relaxants, Central; Parasympatholytics; Quinoxalines | 1963 |
Acute treatment of noise trauma with local caroverine application in the guinea pig.
Topics: Administration, Topical; Animals; Evoked Potentials, Auditory, Brain Stem; Female; Guinea Pigs; Hearing Loss, Noise-Induced; Male; Quinoxalines; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Round Window, Ear; Time Factors | 2003 |
Caroverine, a multifunctional drug with antioxidant functions.
Topics: Analysis of Variance; Antioxidants; Glycine max; Hydroxyl Radical; Iron; Lipid Peroxidation; Liposomes; Peroxynitrous Acid; Quinoxalines; Superoxides; Time Factors; Vitamin E | 2003 |
Tinnitus: pharmacological topodiagnosis.
Topics: Amantadine; Anticonvulsants; Audiometry; Auditory Perception; Carbamazepine; Diuretics; Furosemide; Humans; Hyperacusis; Quinoxalines; Tinnitus | 2004 |
Protection of auditory function against noise trauma with local caroverine administration in guinea pigs.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Auditory Threshold; Evoked Potentials, Auditory, Brain Stem; Excitatory Amino Acid Antagonists; Female; Guinea Pigs; Hearing Loss, Noise-Induced; Male; N-Methylaspartate; Noise; Quinoxalines; Random Allocation; Receptors, Glutamate | 2004 |
Topical administration of Caroverine in somatic tinnitus treatment: proof-of-concept study.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Cohort Studies; Female; Humans; Male; Middle Aged; Neurons, Afferent; Prospective Studies; Quinoxalines; Regression Analysis; Surveys and Questionnaires; Synapses; Tinnitus; Treatment Outcome; Tympanic Membrane | 2005 |
Ubiquinol and the papaverine derivative caroverine prevent the expression of tumour- promoting factors in adenoma and carcinoma colon cancer cells induced by dietary fat.
Topics: Adenoma; Carcinoma; Colonic Neoplasms; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dietary Fats; Gene Expression Regulation, Neoplastic; Humans; Linoleic Acids; Lipid Peroxides; Organic Chemicals; Pyrazoles; Quinoxalines; Sulfonamides; Tumor Cells, Cultured; Ubiquinone; Vascular Endothelial Growth Factor A | 2005 |
Low-dose, long-term caroverine administration attenuates impulse noise-induced hearing loss in the rat.
Topics: Animals; Antioxidants; Auditory Fatigue; Brain Stem; Dose-Response Relationship, Drug; Evoked Potentials, Auditory, Brain Stem; Hair Cells, Auditory, Inner; Hair Cells, Auditory, Outer; Hearing Loss, Noise-Induced; Injections, Subcutaneous; Quinoxalines; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate | 2006 |
[Changes of synaptoarchitecture of the retina after the light-induced damage and their correction by plant antioxidants].
Topics: Administration, Oral; Animals; Antioxidants; Ascorbic Acid; Light; Male; Quercetin; Quinoxalines; Radiation Injuries, Experimental; Rats; Retina; Synapses; Treatment Outcome | 2008 |
Changes in the synaptoarchitectonics of the retina after light-induced damage and their correction with antioxidants of plant origin.
Topics: Administration, Oral; Animals; Antioxidants; Ascorbic Acid; Light; Male; Quercetin; Quinoxalines; Radiation Injuries, Experimental; Rats; Retina; Synapses; Treatment Outcome | 2009 |
Assessment of caroverine as a potential chemotherapeutical agent in HNSCC cell lines.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Cetuximab; Cisplatin; Dose-Response Relationship, Drug; Fluorouracil; Head and Neck Neoplasms; Immunohistochemistry; Mice; Quinoxalines | 2015 |
A novel spectrophotometric determination of caroverine in pharmaceutical formulations via derivatization with Folin-ciocalteu Phenol reagent.
Topics: Drug Compounding; Drug Stability; Excipients; Indicators and Reagents; Limit of Detection; Molecular Structure; Molybdenum; Quinoxalines; Spectrophotometry; Tablets; Tungsten Compounds | 2018 |